WESTLAKE VILLAGE, CA – Genelux Corporation (NASDAQ:GNLX), a clinical-stage pharmaceutical company with a market capitalization of $134.7 million, announced significant changes in its executive team.

Leerink Partners analyst Thomas Smith adjusted the price target for 89bio Inc . (NASDAQ:ETNB) to $37 from $34, while ...

Researchers at the Indian Institute of Technology, Guwahati, in partnership with leading institutions around the world, have ...

Sarfaraz K. Niazi, PhD, argues that regulatory agencies should eliminate redundant clinical efficacy testing for biosimilars, ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Future development plans include incorporating AI, expanding connectors, and specializing in additional therapeutic areas.

Researchers at the Indian Institute of Technology (IIT) Guwahati, National University of Singapore and University of Michigan have developed an innovative multi-stage clinical trial method aimed at ...

When smart people make irrational choices, we often assume they are acting out of selfishness, stupidity or stubbornness.

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Introduction With the rise of digital technology, many people turn to online tools for medical guidance. A Symptom Checker is one such tool that helps users identify potential health conditions based ...